Read about rhabdomyosarcoma diagnosis stories and the latest in rhabdomyosarcoma research.
Projects will develop new treatments for neuroblastoma, high-grade gliomas, including DMG, and more Bethesda, Md. – February 15, 2022– CureSearch for Children’s Cancer, a national nonprofit with a mission to end childhood cancer by driving targeted and innovative research with measurable results […]
CureSearch announces new funding commitment to childhood cancer research projects Read More »
By Jack Winters My journey with cancer has taught me about the strength of the human spirit. I’m a childhood cancer survivor. As a patient, cancer research advocate and pediatric nurse, I’ve seen hundreds of children and families overcome insurmountable
All of Us Can Take Action to End Childhood Cancer – A Survivor’s Story Read More »
New CureSearch Young Investigator Ranjit Bindra is studying novel targeted drugs for alveolar rhabdomyosarcoma (ARMS). His research promises to stimulate further drug discovery with the ultimate goal of delivering new medications that can be used to treat ARMS and other rare cancers.
Dr. Ranjit Bindra, Young Investigator: Rhabdomyosarcoma Read More »
Jason Yustein, MD, PhD, is a CureSearch Young Investigator studying rhabdomyosarcoma at Baylor College of Medicine. Dr. Yustein’s research focuses on creating new models of mice that spontaneously develop rhabdomyosarcoma (RMS), which are useful because they allow researchers to analyze the genetics and molecular pathways altered in RMS development and progression.
Researcher Studies Gene Pathways Responsible for Metastatic Rhabdomyosarcoma Read More »
